phosphoserine and niacinamide

phosphoserine has been researched along with niacinamide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koh, PO	1
Anderson, DJ; Belvin, M; Chan, J; Chen, H; Friedman, LS; Haling, JR; Hatzivassiliou, G; Heald, R; Hewitt, JF; Hoeflich, KP; Ludlam, MJ; Luoh, SM; Malek, S; Merchant, M; Orr, C; Peck, A; Price, S; Song, K; Ultsch, M; Wiesmann, C; Zak, M	1

Other Studies

2 other study(ies) available for phosphoserine and niacinamide

Article	Year
Nicotinamide attenuates the ischemic brain injury-induced decrease of Akt activation and Bad phosphorylation. Neuroscience letters, 2011, Jul-08, Volume: 498, Issue:2 Topics: 14-3-3 Proteins; Animals; bcl-Associated Death Protein; Cell Survival; Drug Evaluation, Preclinical; Infarction, Middle Cerebral Artery; Male; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Niacinamide; Oxidative Stress; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley	2011
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. Nature, 2013, Sep-12, Volume: 501, Issue:7466 Topics: Allosteric Regulation; Azetidines; Cell Survival; Clinical Trials as Topic; Crystallography, X-Ray; Enzyme Activation; Feedback, Physiological; Genes, ras; HCT116 Cells; Humans; Imidazoles; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Models, Molecular; Neoplasms; Niacinamide; Oncogene Protein p21(ras); Phosphorylation; Phosphoserine; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf	2013

Article

Year

Nicotinamide attenuates the ischemic brain injury-induced decrease of Akt activation and Bad phosphorylation.

Neuroscience letters, 2011, Jul-08, Volume: 498, Issue:2

Topics: 14-3-3 Proteins; Animals; bcl-Associated Death Protein; Cell Survival; Drug Evaluation, Preclinical; Infarction, Middle Cerebral Artery; Male; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Niacinamide; Oxidative Stress; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley

2011

Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers.

Nature, 2013, Sep-12, Volume: 501, Issue:7466

Topics: Allosteric Regulation; Azetidines; Cell Survival; Clinical Trials as Topic; Crystallography, X-Ray; Enzyme Activation; Feedback, Physiological; Genes, ras; HCT116 Cells; Humans; Imidazoles; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Models, Molecular; Neoplasms; Niacinamide; Oncogene Protein p21(ras); Phosphorylation; Phosphoserine; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf

2013